Back to top

Image: Bigstock

Oak Street Health, Inc. (OSH) Surges 5.2%: Is This an Indication of Further Gains?

Read MoreHide Full Article

Oak Street Health, Inc. shares ended the last trading session 5.2% higher at $26.58. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 46.9% gain over the past four weeks.

Share price of Oak Street Health is rising likely in anticipation of a strong second quarter results, scheduled to report early next month.

This company is expected to post quarterly loss of $0.50 per share in its upcoming report, which represents a year-over-year change of -13.6%. Revenues are expected to be $520.1 million, up 47.3% from the year-ago quarter.

While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

For Oak Street Health, Inc., the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on OSH going forward to see if this recent jump can turn into more strength down the road.

The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>

Oak Street Health, Inc. is part of the Zacks Medical - Outpatient and Home Healthcare industry. Chemed (CHE - Free Report) , another stock in the same industry, closed the last trading session 1.2% higher at $504.30. CHE has returned 8.8% in the past month.

For Chemed, the consensus EPS estimate for the upcoming report has remained unchanged over the past month at $4.78. This represents a change of +3.9% from what the company reported a year ago. Chemed currently has a Zacks Rank of #3 (Hold).


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Chemed Corporation (CHE) - free report >>

Published in